Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.26B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$268M |
| 3 |
Baxter International
BAX
|
+$212M |
| 4 |
UnitedHealth
UNH
|
+$185M |
| 5 |
Corteva
CTVA
|
+$169M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 2 |
Microsoft
MSFT
|
+$260M |
| 3 |
Meta Platforms (Facebook)
META
|
+$251M |
| 4 |
Salesforce
CRM
|
+$226M |
| 5 |
Match Group
MTCH
|
+$188M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Legend Biotech
LEGN
$6.11B
| $4.21M | ﹤0.01% |
103,271
+6,700
| +7% | +$273K |
|
1977
Celldex Therapeutics
CLDX
$1.62B
| $4.21M | ﹤0.01% |
149,646
-4,324
| -3% | -$122K |
|
1978
First Commonwealth Financial
FCF
$1.84B
| $4.21M | ﹤0.01% |
327,557
-9,562
| -3% | -$123K |
|
1979
QuantumScape
QS
$5.63B
| $4.21M | ﹤0.01% |
500,029
-14,596
| -3% | -$123K |
|
1980
CryoPort
CYRX
$433M
| $4.2M | ﹤0.01% |
172,282
-8,718
| -5% | -$212K |
|
1981
Opko Health
OPK
$1.11B
| $4.16M | ﹤0.01% |
2,201,636
-483,570
| -18% | -$914K |
|
1982
Kelly Services Class A
KELYA
$481M
| $4.15M | ﹤0.01% |
305,287
-17,017
| -5% | -$231K |
|
1983
Plains GP Holdings
PAGP
$3.7B
| $4.15M | ﹤0.01% |
380,236
+137,830
| +57% | +$1.5M |
|
1984
Trinseo
TSE
$87.7M
| $4.14M | ﹤0.01% |
226,115
-4,577
| -2% | -$83.8K |
|
1985
Granite Construction
GVA
$4.7B
| $4.13M | ﹤0.01% |
162,846
-6,662
| -4% | -$169K |
|
1986
Scansource
SCSC
$974M
| $4.13M | ﹤0.01% |
156,299
+6,518
| +4% | +$172K |
|
1987
Hanmi Financial
HAFC
$748M
| $4.12M | ﹤0.01% |
173,897
-6,972
| -4% | -$165K |
|
1988
CCC Intelligent Solutions
CCCS
$6.37B
| $4.11M | ﹤0.01% |
451,104
+120,964
| +37% | +$1.1M |
|
1989
Triumph Financial, Inc.
TFIN
$1.4B
| $4.1M | ﹤0.01% |
75,459
-1,939
| -3% | -$105K |
|
1990
Expro
XPRO
$1.43B
| $4.09M | ﹤0.01% |
321,218
-5,533
| -2% | -$70.5K |
|
1991
Krispy Kreme
DNUT
$541M
| $4.08M | ﹤0.01% |
353,782
-234,971
| -40% | -$2.71M |
|
1992
Veru
VERU
$50.5M
| $4.08M | ﹤0.01% |
35,379
-4,881
| -12% | -$562K |
|
1993
Interparfums
IPAR
$3.43B
| $4.07M | ﹤0.01% |
53,936
-1,709
| -3% | -$129K |
|
1994
Certara
CERT
$1.81B
| $4.06M | ﹤0.01% |
305,631
-18,288
| -6% | -$243K |
|
|
GTY
1995
Getty Realty Corp
GTY
$1.6B
| $4.03M | ﹤0.01% |
150,013
-5,817
| -4% | -$156K |
|
1996
Nuveen ESG Dividend ETF
NUDV
$31.8M
| $4.03M | ﹤0.01% |
190,100
| – | – |
|
1997
B&G Foods
BGS
$360M
| $4.03M | ﹤0.01% |
244,343
-148,357
| -38% | -$2.45M |
|
1998
TechnipFMC
FTI
$16.4B
| $4.03M | ﹤0.01% |
475,940
-13,460
| -3% | -$114K |
|
1999
AdvanSix
ASIX
$576M
| $4.02M | ﹤0.01% |
125,274
-120,084
| -49% | -$3.85M |
|
|
FMTX
2000
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $4.01M | ﹤0.01% |
200,901
-13,458
| -6% | -$268K |
|